REDWOOD CITY, Calif., May 14, 2018 (GLOBE NEWSWIRE) — Avinger, Inc. (Nasdaq:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today reported results for the first quarter ended March 31, 2018.
Avinger Announces First Quarter 2018 Financial Results
by GlobeNewsWire | May 14, 2018 | Globe Newswire